INBX
Inhibrx Biosciences, Inc.
100.40$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.5% | 95.9% | 95.1% | 93.7% | 93.2% | 88.7% | 92.1% | 91.4% | 91.0% | 90.7% | 93.1% | 92.2% | |
| 90.5% | 90.3% | 87.5% | 87.8% | 88.2% | 84.4% | 89.2% | 88.0% | 86.3% | 84.8% | 87.9% | 86.5% | |
| 90.5% | 90.3% | 87.5% | 87.8% | 88.2% | 84.4% | 89.2% | 88.0% | 86.3% | 84.8% | 87.9% | 86.5% | |
| 0.1% | 0.3% | 1.1% | 0.5% | 0.5% | 0.2% | 0.1% | 0.5% | 0.5% | 0.1% | 0.1% | 0.1% | |
| -0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 65.2% | 85.9% | 96.0% | 15.1% | 19.8% | 26.1% | 61.1% | 67.7% | 79.2% | 94.5% | 111.4% | 134.4% | |
| 9.6% | 18.3% | 24.9% | 15.1% | 19.8% | 22.5% | 18.0% | 18.4% | 20.3% | 23.1% | 14.4% | 18.2% | |
| 0.5% | 0.7% | 2.0% | 0.8% | 0.8% | 0.9% | 0.8% | 1.0% | 1.3% | 1.6% | 1.3% | 1.6% | |
| 2.1% | 3.6% | 4.3% | 5.0% | 5.6% | 5.1% | 3.7% | 3.9% | 3.8% | 4.1% | 4.8% | 6.4% | |
| – | – | – | – | – | – | 40.7% | 46.8% | 56.3% | 68.7% | 95.1% | 114.3% | |
| 34.8% | 14.1% | 4.0% | 84.9% | 80.2% | 73.9% | 38.9% | 32.3% | 20.8% | 5.5% | -11.4% | -34.4% | |
| -139.5% | -199.3% | -240.0% | -5.6% | -26.2% | -58.7% | -61.6% | -84.0% | -120.2% | -168.1% | -152.0% | -205.1% | |
| 12.7% | 17.5% | 18.9% | 5.7% | 6.9% | 8.0% | 6.4% | 7.3% | 8.7% | 10.6% | 8.5% | 10.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.